for 2 hr. Undigested tissue was removed by filtration using a 100 µm mesh. Cells were incubated with 200 µl of 10 µg/mltrastuzumab (Herceptin; Roche, Hertfordshire, U.K.) or without trastuzumab as negative control for 30 min at 4°C, followed by three washes in fluorescence-activated cell sorting (FACS)
buffer (phosphate-buffered saline containing 5% fetal bovine serum). Then, cells were incubated with anti-human IgG APC antibodies (BioLegend) diluted 1:25 for 30 min at 4°C, and washed with
FACS buffer. Negative controls were also subjected to the same procedures. After live cells were gated by forward scatter/side scatter (FSC/SSC), fluorescence was measured and analyzed using
a flow cytometer and its related software (BD FACSVerse™, Becton-Dickinson, Franklin Lakes, NJ, U.S.A.). Staining positivity was confirmed by negative control.